Dialysis treatments at risk amid supply chain issues

A IV bag stands against a grey-blue background.

🩺 Dialysis treatments are in jeopardy amid constant supply chain disruptions.

COVID-19-related supply chain hiccups have unveiled how dependent many vulnerable communities are on their healthcare systems running smoothly. With 37 million Americans diagnosed with chronic kidney disease, medical staffing shortages and a lack of dialysis treatments have policymakers concerned with protecting these patients.

Read more from The Hill ▶

Previous
Previous

Creative sales tactics could change the trajectory of your small business

Next
Next

U.S. Express lays of 5% corporate staff